Objective: Detection of gastric cancer in its early stage is pertinent in reducing disease-specific mortality. However, this has not been achieved in many countries where the incidence of gastric cancer is high. In order to overcome this problem, we developed an e-learning system for international endoscopists to improve endoscopic diagnosis of early gastric cancer. However, it has not been investigated whether such learning system is useful in clinical practice. The objective of this trial is to investigate whether the intensive on-site TTT course is useful for increasing early detection rate of gastric cancer in Chinese high-volume endoscopy center. Methods: Five Chinese doctors (the TTT group) who were invited to the TTT course and the other five age-and experience-matched Chinese doctors (the non-TTT group) in the same facility who did not attend the TTT course were included in this trial. Endoscopists of the TTT group attended 2-day learning course four times from March 20, 2015 to March 25, 2016. Endoscopists of the non-TTT group did not attend any learning program during the same period. Lectures of the TTT course included the detection of early gastric cancer by screening endoscopy using white-light endoscopy alone and the feature of the detected subtle gastric mucosal lesion using white-light endoscopy or magnifying endoscopy with narrow-band imaging. Contents used in the lecture had been reported to be useful by an e-learning trial 1,2 . All the instructions were given by an experienced Japanese endoscopist (K. Y.) who constructed the e-learning system 1, 2 . Endoscopists also received on-site hands-on instructions in order to check whether they obtained enough knowledge and technique. Furthermore, we held case conferences in order to share common experiences. During the period, the number of both newly detected early gastric cancers and screening gastroscopy procedures was recorded. The primary endpoint was to compare the early detection rate between the TTT and the non-TTT group (early detection rate = the number of newly detected early gastric cancers/the number of screening endoscopy procedures). Results: The data obtained from the 256 consecutive cases of screening gastroscopy procedures by the TTT group endoscopists and from the 323 consecutive cases of screening endoscopy procedures by the non-TTT group endoscopists were analyzed. In the TTT group, four cases with early gastric cancers were detected, and no early gastric cancer was detected. There was a significant difference in early detection rate between the TTT and the non-TTT group (Fisher's exact test, P = 0.044). Conclusions: This clinical trial clearly showed that the systematic intensive TTT course is useful for improving early detection rate of gastric cancer in clinical practice at Chinese high-volume endoscopy center (NCT02385578). Background/Aims: The currently used definition of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) was based on the evaluation for more than 24 h after ERCP. However, the consensus for initiation timing of oral nutrition has not yet been established after ERCP. Thus, we design this trial to evaluate the safety and efficacy of early feeding based on 4 h parameter instead of the consensus definition. Methods: Patients who complained no pancreatictype abdominal pain within 1.5-fold amylase value were randomized to start early feeding since 4 h or standard feeding since 24 h after ERCP. The primary outcome was the incidence of PEP more than 24 h after ERCP. The secondary outcomes were defined as efficacy of early feeding. Results: Five hundred sixty-four patients who underwent ERCP were assessed for eligibility of study. Among them, 276 patients after exclusion for 251 patients with other reasons as well as 37 patients with a 1.5-fold or more amylase values were randomized equally to early feeding group or standard feeding group. PEP was identified in three patients (2.2%) of the early feeding group and five patients (3.6%) of the standard feeding group, without significant difference (P = 0.72). Overall, PEP was occurred in 26 patients (8.3%) among 313 patients (18 patients among those with a 1.5-fold or more amylase values). In particular, the medical expenses for ERCP is significantly higher in standard feeding group (USD1311.2 ± 628.0) than early feeding group (USD1157.2 ± 555.5) (P = 0.032) although the length of hospitalization was not different between both groups. Conclusion: Early feeding based on 4 h evaluation after ERCP was non-inferior to standard feeding in terms of the incidence of PEP. Key words: consensus definition, endoscopic retrograde cholangiopancreatography; pancreatitis; re-feeding; serum amylase. Background: There is strong concern among GOASIA experts on the emergence of obesity-related gastrointestinal (GI) diseases in Asia, but it is unknown if differences exist in perception and bariatric practices among Asian GI practitioners. Methods: A 52-item questionnaire with 10-point Likert responses (strongly disagree 0, neutral 5, and strongly agree 10) was developed. Six experts were invited for content validity and 22 respondents for face validity. Asian practitioners in different settings (physician vs surgeon, government vs private, and experienced vs less experienced based on volume of consultations per week) were invited to answer online questionnaire. Scores reported in mean ± standard deviation and associations evaluated with multiple logistic regression (backward LR). Results: Three hundred and seventy-seven participants from 10 Asian countries (Malaysia, Thailand, India, the Philippines, Korea, Taiwan, Japan, Singapore, Hong Kong, and Indonesia) took part (response rate 75%). Participants were males 71%, physicians 89%, government practice 81%, and experienced practice 58%. Asian practitioners were neutral in perception of obesity association with cancers (5.7 ± 2.1) and other GI diseases (5.3 ± 2.1). They practiced less bariatric surgery for obesity (3.7 ± 2.8) and non-alcoholic fatty liver disease (NAFLD) (2.4 ± 2.7) and, likewise, endoscopic bariatric therapy for obesity (2.9 ± .2.9) and NAFLD (2.3 ± 2.7). A reason was less bariatric practices among physicians than surgeons (3.5 vs 5.9, P = 0.01). Side effects of bariatric surgery were more concerned by private than government practitioners (6.2 vs 5.5, P = 0.03). Bariatric surgery was less in experienced versus less-experienced practice (6.7 vs 6.0, P = 0.001) because of motivated patients and their adherence to dietary and physical interventions. (HR 5.04, 6.65 and 8.34 for ≥1, ≥2, and ≥3 years, respectively). The adjusted absolute risk difference for PPI versus non-PPI use was 4.29 excess GC (95% CI: 1.25-9.54) per 10 000 person-years. Subgroup analysis showed the risk was confined to non-cardia (HR 2.59, 95% CI: 1.42-4.72) but not cardia GC. Conclusions: Long-term PPI use was associated with an increased GC risk in subjects even after HP eradication.
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Background/Aim: Functional gastrointestinal disorders (FGIDs) are diagnosed by the presence of a characteristic set of symptoms. However, the current criteria-based diagnostic approach is to some extent subjective and largely derived from observations in English-speaking patients from the West. We aimed to identify latent symptom clusters in Asian FGID patients. Methods: One thousand eight hundred five consecutive unselected FGID patients who presented for primary or secondary care to 11 centers across Asia completed a cultural and linguistic adaptation of the Rome III diagnostic questionnaire. Principal components factor analysis with varimax rotation was used to identify symptom clusters. A cluster analysis within the cohort was also performed to identify underlying pathophysiology pattern. Results: Nine symptom clusters were identified, consisting of two esophageal factors (F6 globus, odynophagia, and dysphagia; F9 chest pain and heartburn), two gastroduodenal factors (F5 bloating, fullness, belching, and flatulence; F8 regurgitation, nausea, and vomiting), three bowel factors (F2 abdominal pain with diarrhea; F3 meal-related and bowel-related; F7 upper abdominal pain with constipation), and two anorectal factors (F1 anorectal pain with constipation; F4 diarrhea, urgency, and incontinence). The most prevalent cluster was F2 (diarrhea with abdominal pain) followed by F5 (bloating, fullness, belching, and flatulence) and F7 (constipation and upper abdominal pain). Cluster analysis identified four groups with high scores on: IBS-like, meal-related, motility related and painful symptoms. Conclusion: There are latent symptom clusters that are not uncommon in Asian FGID patients. Future studies to compare a non-Asian cohort and to match to putative pathophysiology will help to verify our findings.
